QSAR modelling, molecular docking, molecular dynamic and ADMET prediction of pyrrolopyrimidine derivatives as novel Bruton’s tyrosine kinase (BTK) inhibitors

Mourad Aloui; Mohammed Er-rajy; Hamada Imtara; Amina Goudzal; Sara Zarougui; Mohamed El fadili; David E. Arthur; Ramzi A. Mothana; Omar M. Noman; Mahmoud Tarayrah; Elhalaoui Menana

doi:10.1016/j.jsps.2023.101911

Q1 2024

QSAR modelling, molecular docking, molecular dynamic and ADMET prediction of pyrrolopyrimidine derivatives as novel Bruton’s tyrosine kinase (BTK) inhibitors

Mourad Aloui · Mohammed Er-rajy · Hamada Imtara · Amina Goudzal · Sara Zarougui · Mohamed El fadili · David E. Arthur · Ramzi A. Mothana · Omar M. Noman · Mahmoud Tarayrah · Elhalaoui Menana

10.1016/j.jsps.2023.101911 383 Views 18 Citations

Citations

383

Views

Abstract not available for this publication.

Cite this Article (APA)

Mourad, A., Mohammed, E., Hamada, I., Amina, G., Sara, Z., Mohamed, E. F., David, E. A., Ramzi, A. M., Omar, M. N., Mahmoud, T., Elhalaoui, M. (2024). QSAR modelling, molecular docking, molecular dynamic and ADMET prediction of pyrrolopyrimidine derivatives as novel Bruton’s tyrosine kinase (BTK) inhibitors. Saudi Pharmaceutical Journal. https://doi.org/10.1016/j.jsps.2023.101911